These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 15470152)
1. Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. Zu T; Duvick LA; Kaytor MD; Berlinger MS; Zoghbi HY; Clark HB; Orr HT J Neurosci; 2004 Oct; 24(40):8853-61. PubMed ID: 15470152 [TBL] [Abstract][Full Text] [Related]
2. Progress in pathogenesis studies of spinocerebellar ataxia type 1. Cummings CJ; Orr HT; Zoghbi HY Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309 [TBL] [Abstract][Full Text] [Related]
3. Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice. Clark HB; Orr HT J Neuropathol Exp Neurol; 2000 Apr; 59(4):265-70. PubMed ID: 10759181 [TBL] [Abstract][Full Text] [Related]
4. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Emamian ES; Kaytor MD; Duvick LA; Zu T; Tousey SK; Zoghbi HY; Clark HB; Orr HT Neuron; 2003 May; 38(3):375-87. PubMed ID: 12741986 [TBL] [Abstract][Full Text] [Related]
5. Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice. Skinner PJ; Vierra-Green CA; Emamian E; Zoghbi HY; Orr HT Neuromolecular Med; 2002; 1(1):33-42. PubMed ID: 12025814 [TBL] [Abstract][Full Text] [Related]
6. Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice. Serra HG; Byam CE; Lande JD; Tousey SK; Zoghbi HY; Orr HT Hum Mol Genet; 2004 Oct; 13(20):2535-43. PubMed ID: 15317756 [TBL] [Abstract][Full Text] [Related]
7. Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy. Vig PJ; Hearst S; Shao Q; Lopez ME; Murphy HA; Safaya E Cerebellum; 2011 Jun; 10(2):254-66. PubMed ID: 21384195 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1. Oz G; Nelson CD; Koski DM; Henry PG; Marjanska M; Deelchand DK; Shanley R; Eberly LE; Orr HT; Clark HB J Neurosci; 2010 Mar; 30(10):3831-8. PubMed ID: 20220018 [TBL] [Abstract][Full Text] [Related]
9. SUMO-1 interacts with mutant ataxin-1 and colocalizes to its aggregates in Purkinje cells of SCA1 transgenic mice. Kang S; Hong S Arch Ital Biol; 2010 Dec; 148(4):351-63. PubMed ID: 21308649 [TBL] [Abstract][Full Text] [Related]
10. Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability. Dell'Orco JM; Wasserman AH; Chopra R; Ingram MA; Hu YS; Singh V; Wulff H; Opal P; Orr HT; Shakkottai VG J Neurosci; 2015 Aug; 35(32):11292-307. PubMed ID: 26269637 [TBL] [Abstract][Full Text] [Related]
11. SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776. Duvick L; Barnes J; Ebner B; Agrawal S; Andresen M; Lim J; Giesler GJ; Zoghbi HY; Orr HT Neuron; 2010 Sep; 67(6):929-35. PubMed ID: 20869591 [TBL] [Abstract][Full Text] [Related]
12. USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product. Hong S; Kim SJ; Ka S; Choi I; Kang S Mol Cell Neurosci; 2002 Jun; 20(2):298-306. PubMed ID: 12093161 [TBL] [Abstract][Full Text] [Related]
13. Relationship between ataxin-1 nuclear inclusions and Purkinje cell specific proteins in SCA-1 transgenic mice. Vig PJ; Subramony SH; Qin Z; McDaniel DO; Fratkin JD J Neurol Sci; 2000 Mar; 174(2):100-10. PubMed ID: 10727695 [TBL] [Abstract][Full Text] [Related]
15. Partial loss of Tip60 slows mid-stage neurodegeneration in a spinocerebellar ataxia type 1 (SCA1) mouse model. Gehrking KM; Andresen JM; Duvick L; Lough J; Zoghbi HY; Orr HT Hum Mol Genet; 2011 Jun; 20(11):2204-12. PubMed ID: 21427130 [TBL] [Abstract][Full Text] [Related]
16. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Klement IA; Skinner PJ; Kaytor MD; Yi H; Hersch SM; Clark HB; Zoghbi HY; Orr HT Cell; 1998 Oct; 95(1):41-53. PubMed ID: 9778246 [TBL] [Abstract][Full Text] [Related]
17. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Watase K; Weeber EJ; Xu B; Antalffy B; Yuva-Paylor L; Hashimoto K; Kano M; Atkinson R; Sun Y; Armstrong DL; Sweatt JD; Orr HT; Paylor R; Zoghbi HY Neuron; 2002 Jun; 34(6):905-19. PubMed ID: 12086639 [TBL] [Abstract][Full Text] [Related]
18. Altered Purkinje cell miRNA expression and SCA1 pathogenesis. Rodriguez-Lebron E; Liu G; Keiser M; Behlke MA; Davidson BL Neurobiol Dis; 2013 Jun; 54():456-63. PubMed ID: 23376683 [TBL] [Abstract][Full Text] [Related]
19. Focused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model. Hearst SM; Shao Q; Lopez M; Raucher D; Vig PJ Cerebellum; 2014 Oct; 13(5):596-606. PubMed ID: 24930030 [TBL] [Abstract][Full Text] [Related]
20. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Cummings CJ; Reinstein E; Sun Y; Antalffy B; Jiang Y; Ciechanover A; Orr HT; Beaudet AL; Zoghbi HY Neuron; 1999 Dec; 24(4):879-92. PubMed ID: 10624951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]